Schonfeld Strategic Advisors LLC
Position in RCUS — Arcus Biosciences, Inc.
CIK 1665241
NEW YORK, NY
Position in RCUS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,778,956
-$401,961 QoQ
Shares Held
122,574
-36.7% QoQ
Ownership
0.096%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#65
of 230 holders
Holding Since
Dec 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RCUS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Schonfeld Strategic Advisors LLC holds $420,669,608 across 133 Biotechnology names. RCUS ranks #30 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INBX |
Inhibrx Biosciences, Inc.
|
697,586 | $66,096,273 | |
| 2 | AGIO |
Agios Pharmaceuticals, Inc.
|
520,083 | $19,300,280 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
77,272 | $18,620,233 | |
| 4 | VRDN |
Viridian Therapeutics, Inc.\DE
|
793,508 | $14,576,741 | |
| 5 | MBX |
MBX Biosciences, Inc.
|
248,670 | $13,726,584 | |
| 6 | XENE |
Xenon Pharmaceuticals Inc.
|
227,330 | $13,721,638 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
147,425 | $12,025,457 | |
| 8 | INSM |
INSMED Inc
|
104,378 | $11,128,782 |
All Filings in RCUS
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,778,956 | 122,574 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $4,180,917 | 193,561 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,318,253 | 97,283 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $664,958 | 48,894 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $438,973 | 53,928 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,071,430 | 136,488 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,010,105 | 134,997 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $10,302,983 | 673,838 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $3,545,452 | 232,794 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,960,876 | 103,860 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $4,408,662 | 230,820 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,565,055 | 142,900 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $3,717,217 | 183,024 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $5,359,094 | 293,810 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $3,191,730 | 154,339 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $3,417,228 | 130,628 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,195,999 | 165,588 | Shares | Sole | 2022-08-15 | |
| 2021-12-31 | $1,007,703 | 24,900 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $850,828 | 24,400 | Shares | Sole | 2021-11-16 | |
| 2021-03-31 | $1,423,684 | 50,701 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $405,625 | 15,625 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||